Severe cytopenia after chimeric antigen receptor‐T cell driven by large granular lymphocytes and responsive to steroids

Immune effector cell-associated hematotoxicity (ICAHT) is a common toxicity associated with an important morbidity after chimeric antigen receptor (CAR)-T-cell therapy. Multiple factors seem to be involved in the development of severe ICAHT, making its management difficult. Here, we report three cases of severe ICAHT after axicabtagene-ciloleucel (axi-cel) for diffuse large B-cell lymphoma showing an expansion of large granular lymphocyte in the bone marrow with a CD3/CD57-positive non-CAR-T immunophenotype. We show that it is possible to treat them with low-dose steroids, obtaining a striking resolution of cytopenias with no deleterious impact on the underlying malignancy.

Authors

Institutions

Publication Details

Journal
British Journal of Haematology
Published
2024-10-19
DOI
https://doi.org/10.1111/bjh.19822
Citations
4
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
1.13
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Severe cytopenia after chimeric antigen receptor‐T cell driven by large granular lymphocytes and responsive to steroids

Éolia Brissot, Antoine Capes, Ludovic Suner, Clémentine Sarkozy et al.
4 citations
British Journal of Haematology
CAR-T cell therapy research
1.13
article

Severe cytopenia after chimeric antigen receptor‐T cell driven by large granular lymphocytes and responsive to steroids

Éolia Brissot, Antoine Capes, Ludovic Suner, Clémentine Sarkozy, Anne Banet, Florent Malard, Alexandra Morin, Nicolas Stocker, Laure Ricard, Zora Marjanovic, Mohamad Mohty, Elise Corre
article en
4 citations

Abstract

Immune effector cell-associated hematotoxicity (ICAHT) is a common toxicity associated with an important morbidity after chimeric antigen receptor (CAR)-T-cell therapy. Multiple factors seem to be involved in the development of severe ICAHT, making its management difficult. Here, we report three cases of severe ICAHT after axicabtagene-ciloleucel (axi-cel) for diffuse large B-cell lymphoma showing an expansion of large granular lymphocyte in the bone marrow with a CD3/CD57-positive non-CAR-T immunophenotype. We show that it is possible to treat them with low-dose steroids, obtaining a striking resolution of cytopenias with no deleterious impact on the underlying malignancy.

British Journal of HaematologyVol. 206(1)
Inserm (FR), Sorbonne Université (FR), Hôpital Saint-Antoine (FR), Centre de Recherche Saint-Antoine (FR), Institut Curie (FR)
Good health and well-being
Openalex Percentile: Top 18%
CAR-T cell therapy research
1.13
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Severe cytopenia after chimeric antigen receptor‐T cell driven by large granular lymphocytes and responsive to steroids — Éolia Brissot, Antoine Capes, et al. · British Journal of Haematology (2024) | TGRS Research Map | TGRS